Analyst Price Targets — TMDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:48 pm | Daniel Markowitz | Evercore ISI | $90.00 | $70.77 | TheFly | TransMedics price target lowered to $90 from $100 at Evercore ISI |
| June 18, 2026 10:36 am | — | Stifel Nicolaus | $80.00 | $73.22 | TheFly | TransMedics price target raised to $80 from $75 at Stifel |
| May 26, 2026 10:50 am | Thomas Stephan | Stifel Nicolaus | $75.00 | $68.94 | TheFly | TransMedics price target lowered to $75 from $85 at Stifel |
| May 6, 2026 1:42 pm | — | Needham | $142.00 | $73.84 | TheFly | TransMedics price target lowered to $142 from $174 at Needham |
| May 6, 2026 11:46 am | William Plovanic | Canaccord Genuity | $124.00 | $94.93 | TheFly | TransMedics price target lowered to $124 from $152 at Canaccord |
| May 6, 2026 11:25 am | — | Piper Sandler | $120.00 | $94.93 | TheFly | TransMedics price target lowered to $120 from $160 at Piper Sandler |
| May 6, 2026 11:23 am | Thomas Stephan | Stifel Nicolaus | $85.00 | $94.93 | TheFly | TransMedics price target lowered to $85 from $130 at Stifel |
| May 6, 2026 10:55 am | David Rescott | Robert W. Baird | $140.00 | $94.93 | TheFly | TransMedics price target lowered to $140 from $157 at Baird |
| March 9, 2026 11:13 am | — | Stifel Nicolaus | $130.00 | $134.77 | TheFly | TransMedics price target raised to $130 from $115 at Stifel |
| December 17, 2025 12:23 pm | — | Canaccord Genuity | $148.00 | $125.04 | TheFly | TransMedics price target raised to $148 from $147 at Canaccord |
Latest News for TMDX
TMDX's PAD Aviation investment expands its OCS model into Europe, aiming to boost organ logistics, utilization and adoption.
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies, and a comprehensive suite of transplant logistics and clinical services. SRTA's asset-light-to-moderate model, strategic acquisitions, and focus on NRP technology position it to benefit from industry consolidation and secular tailwinds. Gross margin improvement is a key near-term catalyst, with management incentivized…
Strategic investment in Germany-based PAD Aviation, a premier European private aviation operator, lays the foundation for TransMedics to establish a dedicated organ transplantation air logistics network across Europe ANDOVER, Mass., July 6, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with…
TransMedics is building more than a medical device business. Its Organ Care System and nationwide transplant logistics network create a difficult-to-replicate competitive advantage.
Investing in attractive stocks on the dip is a great way to earn above-average returns over the long run. The three stocks below have faced some challenges, but their prospects look fairly strong.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TMDX.
U.S. House Trading
No House trades found for TMDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.